Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, China
- the First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
- Beijing Chao-Yang Hospital,capital Medical University
Beijing, Beijing Municipality, China
- Beijing Jishuitan Hospital,capital Medical University
Beijing, Beijing Municipality, China
- the First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
- the Southwest Hospital of Amu
Chongqing, Chongqing Municipality, China
- Gansu Provincial Maternal and Child Health Hospital (gansu Provincial Central Hospital)
Lanzhou, Gansu, China
- Lanzhou University Second Hospital
Lanzhou, Gansu, China
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
- Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
- Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China
- the First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
- the Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
- Cangzhou People'S Hospital
Cangzhou, Hebei, China
- Affiliated Hospital of Chengde Medical University
Chengde, Hebei, China
- the Second Hospital of Hebeimedical University
Shijiazhuang, Hebei, China
- the Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
- Luoyang Central Hospital
Luoyang, Henan, China
- Henan Cancer Hospital
Zhengzhou, Henan, China
- Henan Provincial People'S Hospital
Zhengzhou, Henan, China
- the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
- the Third Xiangya Hospital of Central South University
Changsha, Hunan, China
- Zhuzhou Central Hospital
Zhuzhou, Hunan, China
- Jiangsu Province Hospital
Nanjing, Jiangsu, China
- Zhongda Hospital Southeast University
Nanjing, Jiangsu, China
- the Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
- Jiangxi Provincial People'S Hospital
Nanchang, Jiangxi, China
- the Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
- Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
- the First Affiliated Hospital of Xi'An Jiao Tong University
Xi'an, Shaanxi, China
- the Second Affiliated Hospital of Xi'An Jiaotong University
Xi'an, Shaanxi, China
- Binzhou Medical University Hospital
Binzhou, Shandong, China
- Cancer Hospital of Shandong First Medical University (shandong Cancer Institute,shandong Cancer Hospital)
Jinan, Shandong, China
- Shandong Provincial Hospital Affiliated To Shandong First Medical University（shandong Provincial Hospital）
Jinan, Shandong, China
- Jining No.1 People'S Hospital
Jining, Shandong, China
- Qingdao Municipal Hospital
Qingdao, Shandong, China
- Shanghai Sixth People'S Hospital
Shanghai, Shanghai Municipality, China
- Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China
- Heping Hospital Affiliated To Changzhi Medical College
Changzhi, Shanxi, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2026
- Primary completion
- 31 Dec 2028
- Completion
- 31 Dec 2030
- Last update posted
- 8 May 2026
- Registered enrollment
- 260
- Registry id
- NCT07569757
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.